These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16321443)

  • 1. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
    Brewer GJ; Dick R; Zeng C; Hou G
    J Inorg Biochem; 2006 May; 100(5-6):927-30. PubMed ID: 16321443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticopper therapy against cancer and diseases of inflammation and fibrosis.
    Brewer GJ
    Drug Discov Today; 2005 Aug; 10(16):1103-9. PubMed ID: 16182195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
    Brewer GJ; Dick R; Ullenbruch MR; Jin H; Phan SH
    J Inorg Biochem; 2004 Dec; 98(12):2160-7. PubMed ID: 15541506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
    Hou G; Abrams GD; Dick R; Brewer GJ
    Transl Res; 2008 Nov; 152(5):239-44. PubMed ID: 19010295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
    Brewer GJ; Ullenbruch MR; Dick R; Olivarez L; Phan SH
    J Lab Clin Med; 2003 Mar; 141(3):210-6. PubMed ID: 12624602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
    Hou G; Dick R; Zeng C; Brewer GJ
    Transl Res; 2006 Dec; 148(6):309-14. PubMed ID: 17162252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate.
    Hou G; Dick R; Brewer GJ
    Exp Biol Med (Maywood); 2009 Jun; 234(6):662-5. PubMed ID: 19307461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice.
    Askari FK; Dick R; Mao M; Brewer GJ
    Exp Biol Med (Maywood); 2004 Sep; 229(8):857-63. PubMed ID: 15337842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
    Hou G; Dick R; Zeng C; Brewer GJ
    Transl Res; 2007 May; 149(5):260-4. PubMed ID: 17466925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.
    Hou G; Dick R; Abrams GD; Brewer GJ
    J Lab Clin Med; 2005 Nov; 146(5):299-303. PubMed ID: 16242529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrathiomolybdate is effective in a mouse model of arthritis.
    McCubbin MD; Hou G; Abrams GD; Dick R; Zhang Z; Brewer GJ
    J Rheumatol; 2006 Dec; 33(12):2501-6. PubMed ID: 17143984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
    Brewer GJ; Merajver SD
    Integr Cancer Ther; 2002 Dec; 1(4):327-37. PubMed ID: 14664727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons on autoimmune diabetes from animal models.
    Yang Y; Santamaria P
    Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An early but intense cytokine production within the islets may be predictive for type 1 diabetes occurrence in the Bio Breeding (BB) rat.
    Papaccio G; Graziano A; d'Aquino R; De Francesco F; Puca A; Pedullà M
    J Cell Physiol; 2006 Dec; 209(3):1016-20. PubMed ID: 16972262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrathiomolybdate is partially protective against hyperglycemia in rodent models of diabetes.
    Zeng C; Hou G; Dick R; Brewer GJ
    Exp Biol Med (Maywood); 2008 Aug; 233(8):1021-5. PubMed ID: 18480419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.
    Shultz LD; Pearson T; King M; Giassi L; Carney L; Gott B; Lyons B; Rossini AA; Greiner DL
    Ann N Y Acad Sci; 2007 Apr; 1103():77-89. PubMed ID: 17332083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes.
    Zheng Y; Kreuwel HT; Young DL; Shoda LK; Ramanujan S; Gadkar KG; Atkinson MA; Whiting CC
    Ann N Y Acad Sci; 2007 Apr; 1103():45-62. PubMed ID: 17376834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
    Khan MK; Mamou F; Schipper MJ; May KS; Kwitny A; Warnat A; Bolton B; Nair BM; Kariapper MS; Miller M; Brewer G; Normolle D; Merajver SD; Teknos TN
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):333-8. PubMed ID: 16549755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risks of free copper in the body and the development of useful anticopper drugs.
    Brewer GJ
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):727-32. PubMed ID: 18827576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.